A systematic review and meta-analysis of robot-assisted vs. open radical cystectomy: where do we stand and future perspective.

Journal: Minerva urology and nephrology
Published Date:

Abstract

INTRODUCTION: Radical cystectomy represents the standard of care for localized muscle invasive or high-grade non-muscle invasive BCG unresponsive bladder cancer. Several randomized control trials have been published comparing open (ORC) with robot-assisted radical cystectomy (RARC). We aimed to summarize evidence in this setting with a systematic review and meta-analysis.

Authors

  • Giuseppe Fallara
    Division of Experimental Oncology, Unit of Urology, URI, IRCCS San Raffaele Hospital, Milan, Italy.
  • Fabrizio Di Maida
    Department of Urology, University of Florence, Careggi Hospital, Florence, Italy.
  • Carlo A Bravi
    Department of Urology, Onze-Lieve-Vrouwziekenhuis Hospital, Aalst, Belgium; ORSI Academy, Ghent, Belgium; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy. Electronic address: carloandrea.bravi@gmail.com.
  • Ruben De Groote
    ORSI Academy Melle Belgium.
  • Federico Piramide
    Department of Urology, "San Luigi Gonzaga" Hospital, University of Turin, Orbassano (Turin), Italy.
  • Filippo Turri
    Department of Urology, University of Modena and Reggio Emilia, Modena, Italy.
  • Iulia Andras
    ORSI Academy, Melle, Belgium.
  • Marcio Moschovas
    AdventHealth Global Robotics Institute, 380 Celebration Place, Celebration, FL, 34747, USA.
  • Alessandro Larcher
    Division of Oncology, Unit of Urology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Alberto Breda
    Department of Urology, Universitat Autònoma de Barcelona, Fundaciò Puigvert, Barcelona, Spain. Electronic address: albbred@hotmail.com.
  • Paolo Dell'Oglio
    Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy; Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.